(Total Views: 830)
Posted On: 04/20/2017 6:11:19 AM
Post# of 72446
Now 28 sites for Prurisol. I thought it was 24 at the end of March.
https://clinicaltrials.gov/ct2/show/study/NCT...5#contacts
I'm looking for the interim data for prurisol, supposed to be released 2nd quarter.
Maybe todays update cc will give us a clue.
Brilacidin is kicking it in gear pretty well imo.
Somethink I'll ask here rather than there, comparison of brilacidin for ABSSSI over iclaprim using vancomycin as a comparator. imo, their results are non inferior though they'll still make it to market before we do. Brilacidin also has the QIDP and fast track as they do but brilacidin has a much better safety profile indeed. I still need to take some time and look closer but that's my take at a glance.
https://www.sec.gov/Archives/edgar/data/16746...ex99d1.htm
https://clinicaltrials.gov/ct2/show/study/NCT...5#contacts
I'm looking for the interim data for prurisol, supposed to be released 2nd quarter.
Maybe todays update cc will give us a clue.
Brilacidin is kicking it in gear pretty well imo.
Somethink I'll ask here rather than there, comparison of brilacidin for ABSSSI over iclaprim using vancomycin as a comparator. imo, their results are non inferior though they'll still make it to market before we do. Brilacidin also has the QIDP and fast track as they do but brilacidin has a much better safety profile indeed. I still need to take some time and look closer but that's my take at a glance.
https://www.sec.gov/Archives/edgar/data/16746...ex99d1.htm
(0)
(0)
